← Open Payments lookup

MEGAN GERWITZ: Open Payments

NPI 1609632926 · KENMORE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,721 in 52 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $832 · 2025 $1,721

Food & beverage: $1,676Education: $45
CompanyPaymentsAmount
Amgen Inc.10$570
AstraZeneca Pharmaceuticals LP7$366
ACADIA Pharmaceuticals Inc1$125
Corcept Therapeutics6$114
GlaxoSmithKline, LLC.4$74
Bayer Healthcare Pharmaceuticals Inc.4$71
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$62
Boehringer Ingelheim Pharmaceuticals, Inc.3$48
Lilly USA, LLC1$45
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$37

Products named: OTEZLA, BREZTRI, REPATHA, NUPLAZID, Korlym, KRYSTEXXA, AIRSUPRA, TRELEGY ELLIPTA.

Industry payments across NY — which companies pay providers there.